Late-stage melanoma: Experimental drug combo puts 50% of patients into remission

A new trial suggests that combining two drugs can help some 50% of patients with stage IV melanoma, a form of skin cancer, achieve full remission.

Tuesday, January 3, 2023 at 1:15 pm